학술논문

Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; MAR 1 2021, 27 5, p1452-p1462, 11p.
Subject
Language
English
ISSN
15573265